Medical News: FDA to Review GH Safety - in Endocrinology, Growth Disorders from MedPage Today
Links shared publicly online about this topic.
- 636total visits
Medical News: FDA to Review GH Safety - in Endocrinology, Growth Disorders from MedPage Today
Following the lead of its European counterpart, the FDA has begun a review of the safety of somatotropin agents in light of a French study suggesting increased deaths among adults treated with the gro
View full resource at medpagetoday.com
Tags: Endocrinology, Disease and Condition, FDA, News, Mortality, Safety
Most Recently Shared on December 22, 2010 at 10:48 pm By:
FDA to Review GH Safety : Endocrinology, Growth http://tinyurl.com/23zuo7j
Medical News: FDA to Review GH Safety - in Endocrinology, Growth Disorders from MedPage Today
medpagetoday.com — “Following the lead of its European counterpart, the FDA has begun a review of the safety of somatotropin agents in light of a French study suggesting increased deaths among adults treated with the gro” View full resource at medpagetoday.com
Most Recently Shared on December 22, 2010 at 10:24 pm By:
FDA to Review GH Safety http://bit.ly/f3ks71
Advertisement
